CFTR and cystic fibrosis: The fact that, even after treatment with correctors, the expression of the F508del-CFTR did not reach the level of WT once more shows the impelling necessity to develop cystic fibrosis therapeutics with a higher target affinity as well as an improved corrective efficacy.